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Abstract
Introduction: We wanted to determine the number of cold bolus injections that are necessary for achieving an
acceptable level of precision for measuring cardiac index (CI), indexed global end-diastolic volume (GEDVi) and
indexed extravascular lung water (EVLWi) by transpulmonary thermodilution.
Methods: We included 91 hemodynamically stable patients (age 59 (25% to 75% interquartile range: 39 to 79)
years, simplified acute physiologic score (SAPS)II 59 (53 to 65), 56% under norepinephrine) who were monitored by
a PiCCO2 device. We performed five successive cold saline (15 mL, 6°C) injections and recorded the measurements
of CI, GEDVi and EVLWi.
Results: Considering five boluses, the coefficient of variation (CV, calculated as standard deviation divided by the
mean of the five measurements) was 7 (5 to 11)%, 7 (5 to 12)% and 7 (6 to 12)% for CI, GEDVi and EVLWi,
respectively. If the results of two bolus injections were averaged, the precision (2 × CV/√ number of boluses) was
10 (7 to 15)%, 10 (7 to 17)% and 8 (7 to 14)% for CI, GEDVi and EVLWi, respectively. If the results of three bolus
injections were averaged, the precision dropped below 10%, that is, the cut-off that is generally considered as
acceptable (8 (6 to 12)%, 8 (6 to 14)% and 8 (7 to 14)% for CI, GEDVi and EVLWi, respectively). If two injections
were performed, the least significant change, that is, the minimal change in value that could be trusted to be
significant, was 14 (10 to 21)%, 14 (10 to 24)% and 14 (11 to 23)% for CI, GEDVi and EVLWi, respectively. If three
injections were performed, the least significant change was 12 (8 to 17)%, 12 (8 to 19)% and 12 (9 to 19)% for CI,
GEDVi and EVLWi, respectively, that is, below the 15% cut-off that is usually considered as clinically relevant.
Conclusions: These results support the injection of at least three cold boluses for obtaining an acceptable
precision when transpulmonary thermodilution is used for measuring CI, GEDVi and EVLWi.
Introduction
Transpulmonary thermodilution (TPTD) is increasingly
u s e di nt h ec l i n i c a la r e a[ 1 ] ,b u ti t sp r e c i s i o nf o rm e a -
suring CI and the number of cold boluses that must be
replicated is a matter of debate. Indeed, a recent study
concluded that calculating the mean of two TPTD mea-
surements was enough for reaching an acceptable level
o fp r e c i s i o n[ 2 ]b u ti ti n c l u d e dal i m i t e dn u m b e ro f
patients. Additionally, for another transpulmonary dilu-
tion technique using the lithium and not the cold dilu-
t i o n ,i th a sb e e nr e c e n t l ys h o w nt h a ta tl e a s tt h r e e
dilution measurements were required for reaching an
acceptable precision. In addition to CI, TPTD also
allows estimating the global end-diastolic volume
(GEDV, that is, the volume of the cardiac cavities at
end-diastole) and the extravascular lung water (EVLW,
that is, the volume of the pulmonary edema) [3]. The
precision of EVLW measurement derived from TPTD
has been reported by some studies [2,4-6], but again,
the number of cold injectates that is needed for obtain-
ing an acceptable reproducibility of the measurements
remains to be determined. As for GEDV, its precision
has been investigated in one study only [2].
Thus, we attempted to answer the important practical
question to know the number of thermal injections that
must be performed for assessing CI, GEDV and EVLW
with an acceptable precision. In particular, we evaluated
the number of thermodilution measurements that must
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EVLW ≥15% with an acceptable confidence. We also
analyzed the factors influencing the precision of the
measurements.
Materials and methods
Patients
This prospective study was conducted in the 15-bed
intensive care unit of a university hospital. As approved
by the Institutional Review Board of our institution,
patients were included according to an emergency pro-
cedure. A deferred informed consent was asked from
the patient’s surrogate as soon as possible. As he/she
recovered consciousness, a deferred informed consent
was asked from the patient. If the patient or his/her
next of kin refused to consent, the patient’s data were
not entered into analysis.
Patients were included if they had a femoral arterial
catheter (Pulsiocath PV2015L20N, Pulsion Medical Sys-
tems, Munich, Germany) and an internal jugular cathe-
ter in place and were routinely monitored by a PiCCO2
device (Pulsion Medical Systems, Munich, Germany).
Patients were excluded if they were less than 18 years
old and if haemodynamic instability did not allow the
mean arterial pressure to remain stable (changes by
more than 10%) during at least five minutes before
starting the study. Patients with cardiac arrhythmias
were not excluded. No patient had a pacemaker.
Study design and measurements
Immediately after inclusion, one of the investigators
(RP) injected five successive cold boluses, each accord-
ing to the manufacturer’s recommendation [7]. For each
bolus, we injected 15 mL 0.9% saline at 6°C through the
distal port of the internal jugular catheter. The injection
was performed as rapidly as possible, irrespective of the
respiratory cycle. The injectate temperature was care-
fully checked to be <6°C for all boluses, as displayed by
the PiCCO device. For ensuring that boluses were <6°C,
we used two packs of saline, one frozen and one at 6°C.
For each bolus, we sampled 20 mL from the 6°C saline
pack, injected it into the iced pack and re-sampled 15
mL from this saline that had been cooled by the contact
with ice. These 15 mL were used for performing the
bolus. The thermodilution curve recorded by the arterial
thermistance was automatically analyzed by the PiCCO2
device, allowing obtaining the value of cardiac output, of
GEDV indexed for body surface (GEDVi) and of EVLW
indexed for predicted body weight (EVLWi). The five
boluses were performed one after another, as soon as
blood temperature had returned to its baseline value, as
indicated by the device. The values of CI, GEDVi and
EVLWi obtained from each thermodilution were
collected. No thermodilution curve was rejected from
analysis. Treatments were kept unchanged and patients
were not mobilized during the study period. All mea-
surements were performed by the same operator (RP).
Data analysis
In each patient, we calculated the coefficient of variation
(CV) of the TPTD variables (CI, GEDVi and EVLWi).
T h eC Vi san o r m a l i z e dm e a s u r eo fd i s p e r s i o no fa
probability distribution. It was calculated as being the
standard deviation divided by the mean of the five mea-
surements. This relatively large number of measure-
ments thus allowed obtaining a reliable value of CV.
The coefficient of error (CE) was obtained by using the
formula CE = CV/√n, were n was the number of repli-
cates of measurements in each patient. The precision
was calculated as being two CV for a single measure-
ment and two CE for averaged measurements. It is
usually considered that a measurement precision level
≤10% is desirable [8]. The least significant change (LSC)
is the minimum change that needs to be measured by a
device in order to recognize a real change of measure-
ment [9]. The LSC was calculated using the following
equation: LSC = CE × 1.96 × √2.
All data except CE, precision, LSC and the dose of
norepinephrine were normally distributed (Kolmogorov-
Smirnov test for normality) and were expressed as med-
ian (25 to 75% interquartile range). As we initially
planned to divide our population into five different sub-
groups depending upon the value of CI, we planned to
include a sufficient number of patients (100) for reach-
ing a normal distribution of CI in all subgroups. A P-
value <0.05 was considered statistically significant. The
statistical analysis was performed with MedCalc 8.1.0.0
(Mariakerke, Belgium).
Results
Patients’ characteristics
A hundred different patients were initially included in
the study. Their characteristics are detailed in Table 1.
In nine patients, the TPTD could not measure any vari-
able, likely due to low CI, as suggested by the values
observed during the preceding hours. The PiCCO device
was instituted due to septic shock in 80% of patients in
all patients and it was in place since 28 (5 to 50) hours.
Atrial fibrillation was observed in 20% of patients (Table
1). Eighty-three percent of patients were under mechani-
cal ventilation and 74% were sedated. A spontaneous
breathing activity was observed in 23 (26%) patients.
Eight patients were under continuous veno-venous
hemofiltration for renal replacement therapy. The dialy-
sis catheter was inserted in the jugular vein and the
blood pump flow was 300 mL/minute.
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Considering five boluses, the average CI was 3.5 (2.7 to
4.3) L/minute/m
2, the GEDVi was 812 (708 to 932) mL/
m
2 and the EVLWi was 9 (8 to 14) mL/kg (Table 1).
The precision for one single measurement was 14 (10 to
21)% for CI, 15 (10 to 24)% for GEDVi and 15 (11 to
24)% for EVLWi and the precision for CI was ≥10% in
66 patients. If two boluses were used for TPTD, the pre-
cision was reduced to 10 (7 to 15)% for CI, 10 (7 to
17)% for GEDVi, 10 (8 to 17)% for EVLWi (Figure 1)
and the precision for CI was ≥10% in 47 patients. If
three boluses were used for TPTD, the precision was
reduced to 8 (6 to 12)% for CI, 8 (6 to 14)% for GEDVi,
8 (7 to 14)% for EVLWi (Figure 1) and the precision for
CI was ≥10% in 33 patients.
T h eL S C( f o ro n es i n g l em e a s u r e m e n t )w a s2 0( 1 4t o
29)% for CI, 20 (14 to 34)% for GEDVi and 20 (16 to
33)% for EVLWi. If two boluses were used for TPTD,
the LSC was reduced to 14 (10 to 21)% for CI, 14 (10 to
24)% for GEDVi and 14 (11 to 23)% for EVLWi (Figure
2). If three boluses were used for TPTD, the LSC was
12 (8 to 17)% for CI, 12 (8 to 19)% for GEDVi and 12
(9 to 19)% for EVLWi (Figure 2).
Factors influencing the precision of the transpulmonary
measurements
Excluding the eight patients under continuous veno-
venous hemofiltration did not significantly change CV,
neither for CI (8 (6 to 12) vs. (8 (6 to 12) for three
measurements) nor for GEDVi (8 (5 to 13) vs. 8 (5 to
13) for three measurements) and EVLWi (8 (6 to 14)
vs. 8 (6 to 14) for three measurements). Excluding the
23 patients with spontaneous breathing activity did
not significantly change CV, neither for CI (8 (5 to
12) vs. (8 (6 to 12) for three measurements) nor for
GEDVi (8 (5 to 13) vs. 8 (5 to 13) for three measure-
ments) and EVLWi (8 (6 to 13) vs. 8 (6 to 14) for
three measurements). There was no significant corre-
lation between the dose of norepinephrine and the
precision of CItd (P = 0.06), GEDVi (P =0 . 1 0 )a n d
EVLWi (P = 0.91).
Table 1 Patients characteristics at baseline
Age (years, median (25% to 75% IQR)) 59 (39 to 79)
Gender (M/F) 65/26
SAPS II (median (25% to 75% IQR)) 59 (53 to 65)
Height (cm, median (25% to 75% IQR)) 175 (170 to 180)
Weight (kg, median (25% to 75% IQR)) 80 (68 to 92)
Cause of shock
septic (n, %) 73 (80)
cardiogenic (n, %) 10 (11)
hypovolemic (n, %) 8 (9)
Catecholamines
norepinephrine (n, %) 51 (56)
dobutamine (n, %) 7 (8)
Heart rate (beats/minute, median (25% to 75% IQR)) 86 (70 to 99)
Mean arterial pressure (mmHg, median (25% to
75% IQR))
80 (72 to 90)
Body temperature (°C, median (25% to 75% IQR)) 37.1 (36.4 to 37.5)
Cardiac rhythm
sinus rhythm (n, %) 72 (79)
atrial fibrillation (n, %) 18 (20)
frequent atrial extrasystoles (n, %) 1 (1)
Cardiac index (L/minute/m
2, median
(25% to 75% IQR))
3.5 (2.7 to 4.3)
EVLWi (mL/kg, median (25% to 75% IQR)) 9 (8 to 14)
GEDVi (mL/m
2, median (25% to 75% IQR)) 812 (705 to 932)
N=9 1
Data are expressed as median (25% to 75% interquartile range (IQR)) or as n
(%).
SAPS, Simplified Acute Physiologic Score; EVLWi, extravascular lung water
indexed for predicted body weight; GEDVi, global end-diastolic volume
indexed for body surface.
Figure 1 Relationship between the number of measurements
and the precision of transpulmonary thermodilution variables.
CI: cardiac index, GEDVi: global end-diastolic volume indexed for
body surface, EVLWi: extravascular lung water indexed for predicted
body weight. For instance, if a precision of ±10% would be desired,
one would have to take the mean of three measurements. (Data are
expressed as medians and 25 to 75% interquartile ranges).
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This study shows that three thermodilution measure-
ments are required for estimating CI, GEDVi and
EVLWi through TPTD with an acceptable level of preci-
sion. If three thermodilution measurements are aver-
aged, the technique allows detecting changes in CI,
GEDVi and EVLWi of more than 15% with an accepta-
ble confidence.
There have been a number of studies reporting a good
agreement between the measurement of CI by TPTD
and by bolus pulmonary artery thermodilution [10-16]
or by the Fick method [17,18]. By showing bias and lim-
its of agreement of the TPTD CI compared to the refer-
ence CI, these previous studies investigated the
technique accuracy [1], that is, its ability to give a value
of CI that is close to the reference value [9].
Nevertheless, validation of a technique monitoring CI
should not only be based upon accuracy. Another key
criterion to consider is precision, that is, the ability of
the technique to provide values of CI that are close to
each other [8]. Indeed, precision is a very important cri-
terion for at least two reasons. First, it determines the
least change that can be trusted with confidence as
being significant in clinical practice. This is especially
important for techniques measuring CI [19], since one
is much more interested in variations of CI values over
time than to a given CI value. Second, since precision
increases with the number of measurements, it condi-
tions the minimal number of measurements that must
be replicated in clinical practice.
Our result concerning the precision of the TPTD
measurement of CI is in accordance with two previous
studies [20,21] but in discrepancy with another one [2].
In particular, we found that averaging two measure-
ments only might be insufficient for reaching an accep-
table precision and that three thermodilution
measurements are actually needed. However, the latter
study [2] included a much more limited number of
patients than our study. Interestingly, the precision of
CI measurement we found for TPTD was similar to the
precision reported by Cecconi et al. for another trans-
pulmonary dilution device, the LiDCO system [22]. As
the PiCCO device, this technique uses transpulmonary
dilution but it uses lithium rather than cold saline as a
diluted indicator. The similarity of precision between
the two techniques suggests that their precision is more
influenced by the transpulmonary dilution technique
itself than the nature of the indicator.
We observed that, provided that three thermodilution
measurements were averaged, the precision of the
TPTD measurement of CI was within the 10% limit that
is usually admitted as being desirable [8]. Comparison
with the precision of the bolus pulmonary artery ther-
modilution is somewhat difficult, since the latter was
evaluated by only a few studies. In a 20-year-old study,
Stetz et al. [23] found that precision of pulmonary
artery catheter was similar to that we report with
TPTD. More recently, Nilsson et al. reported a precision
as low as 6% when averaging only three pulmonary
artery thermodilutions [24]. If confirmed, these results
would suggest that pulmonary artery thermodilution is
more precise than TPTD.
The precision was almost similar for CI, GEDVi and
EVLWi. This is not surprising since their measurement
by TPTD share some common components. We could
not analyze some constituents on which the measure-
ment of CI, GEDVi and EVLWi is based, such as the
mean transit time and down slope time of the thermodi-
lution curve, what must be considered as a limitation of
our study. Importantly, we found that the precision of
Figure 2 Relationship between the number of measurements
and the least significant change of transpulmonary
thermodilution variables. CI: cardiac index, GEDVi: global end-
diastolic volume indexed for body surface, EVLWi: extravascular lung
water indexed for predicted body weight. For instance, for assessing
a 15% change in CI, GEDVi or EVLWi with a 95% confidence, one
would have to take the mean of three measurements. (Data are
expressed as medians and 25 to 75% interquartile ranges).
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with cardiac arrhythmias, continuous veno-venous
hemofiltration or spontaneous breathing were excluded
from analysis. The absence of significant correlation
between the dose of norepinephrine and the precision of
CI, GEDVi and EVLWi suggests that vasopressors also
do not influence the precision of TPTD measurements.
The good precision of EVLWi and GEDVi measure-
ments is important as an increasing number of studies
have proposed to consider EVLW as a prognostic factor
[4,5,25] or as a criterion of judgement for therapy [6] in
acute respiratory distress syndrome, even though con-
cerns have been raised concerning its reliability in this
condition [26]. The results of the present study might
have some important implications. The first ones are for
daily clinical practice. By showing that injecting three
cold boluses is sufficient for obtaining an acceptable
precision of the technique, the study supports the man-
ufacturer’sg u i d e l i n e so fa v e r a g i n gt h r e et h e r m o d i l u t i o n
measurements [7], a recommendation that, until now,
was not based upon published data. If one considers
that a precision of 8% is sufficient for CI, GEDVi and
EVLWi, what is highly reasonable [27], repeating more
than three boluses is useless. This might be important
when considering that repeating cold injections is time
consuming and that thermodilution must be frequently
repeated in case of hemodynamic instability [28]. The
second implication of the results is for clinical research
purposes. For instance, it indicates that if three thermo-
dilution measurements are averaged, a change in CI,
GEDVi or EVLWi of 15% or more can be considered as
the cut-off defining a positive response to a therapeutic
intervention [21,29,30].
We acknowledge some limitations to our study. First,
we did not exclude any measurement from analysis,
while less skilled operators should do it when obtaining
less reliable thermodilution curves. Second, the mea-
surements were performed by only one skilled operator,
precluding the assessment of inter-observer variability.
Third, we did not investigate whether injecting more
than 15 mL for performing each bolus could increase
t h ep r e c i s i o no ft h et e c h n i q u e .F o u r t h ,t h eb o d yt e m -
perature, CI, GEDVi and EVLWi values were within the
normal range, such that the precision of TPTD for
extreme values of these variables remains to be deter-
mined. In addition, we did not include patients with
slow atrial fibrillation, which may affect the precision of
TPTD measurements. Also, ideally, the measurements
should have consisted of a series of five boluses com-
pared to another series of five boluses for which one to
five are randomly selected. Finally the precision of
TPTD when using a humeral arterial catheter remains
to be determined.
Conclusions
We found that three thermodilution measurements are
needed for estimating CI, GEDVi and EVLWi with
TPTD. If three thermodilutions measurements were
averaged, this allowed detecting a 12% change in CI,
GEDVi and EVLWi with a 95% certainty. In addition to
the accuracy of the technique, which has been already
reported, these results may reinforce the level of evi-
dence that TPTD is a reliable technique for monitoring
critically ill patients.
Key messages
￿ Three thermodilution measurements are needed
for estimating cardiac index, global end-diastolic
volume and extravascular lung water with transpul-
monary thermodilution
￿ If three thermodilution measurements are aver-
aged, this allows detecting a 12% change in estimat-
ing cardiac index, global end-diastolic volume and
extravascular lung water with a 95% certainty
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